About AOA Dx
AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.
Founded in 2021 by Alexander Fischer, Anna Jeter and Oriana Papin Zoghbi.
- Founded
- 2021
- Employees
- 25
- Total funding
- $24.5M
- Headquarters
- Denver
Leadership
The top of AOA Dx's org chart, with how many people report into each leader.
Oriana Papin-Zoghbi
CEO & Co-Founder
18 reports
Samantha Y.
Developmental Therapeutics Head
5 reports
Abigail McElhinny
Chief Scientific Officer
4 reports
Alex Fisher
Co-Founder
4 reports
Anna Milik Jeter
Chief Regulatory Officer And Co-founder
Anna Jeter
Chief Regulatory Officer And Co-founder
Board
Surbhi Sarna
Advisor
Elizabeth Garner
Advisor
Larry Kessler
Advisor
Amy Skubitz
Advisor
Kevin Elias
Advisor
Uri Saragovi
Advisor
Jobs at AOA Dx
No open positions right now. Explore more companies on TheJobsMap.